๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—† Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—†
Updated 04 Jul 2026 ยท HPRA open data

Apixaban - Medicines in Ireland

32 authorised products containing Apixaban, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
Showing 32 authorised medicines
MedicineActive substanceLicence holderStatus
Apixaban 2.5 mg film-coated tablets
PA22865/009/001
Apixaban Renata Pharmaceuticals (Ireland) Limited Not marketed
Apixaban 5 mg film-coated tablets
PA22865/009/002
Apixaban Renata Pharmaceuticals (Ireland) Limited Not marketed
Apixaban Abdi 2.5 mg film-coated tablet
PA23405/002/001
Apixaban Abdi Farma GmbH Not marketed
Apixaban Abdi 5 mg film-coated tablet
PA23405/002/002
Apixaban Abdi Farma GmbH โ€”
Apixaban Accord 2.5 mg film-coated tablets
EU/1/20/1458/001-020
Apixaban Accord Healthcare S.L.U. โ€”
Apixaban Accord 5 mg film-coated tablets
EU/1/20/1458/021-046
Apixaban Accord Healthcare S.L.U. โ€”
Apixaban Clonmel 2.5 mg film-coated tablets
PA0126/328/001
Apixaban Clonmel Healthcare Ltd Not marketed
Apixaban Clonmel 5 mg film-coated tablets
PA0126/328/002
Apixaban Clonmel Healthcare Ltd Not marketed
Apixaban Grindeks 2.5 mg film-coated tablets
PA22992/020/001
Apixaban AS Grindeks Not marketed
Apixaban Grindeks 5 mg film-coated tablets
PA22992/020/002
Apixaban AS Grindeks Not marketed
Apixaban Krka 2.5 mg film-coated tablets
PA1347/107/001
Apixaban KRKA, d.d., Novo mesto Not marketed
Apixaban Krka 5 mg film-coated tablets
PA1347/107/002
Apixaban KRKA, d.d., Novo mesto Not marketed
Apixaban MSN 2.5 mg film-coated tablets
PA23250/013/001
Apixaban MSN Labs Europe Limited Not marketed
Apixaban MSN 5 mg film-coated tablets
PA23250/013/002
Apixaban MSN Labs Europe Limited Not marketed
Apixaban Pinewood 2.5 mg film-coated tablets
PA0281/259/001
Apixaban Pinewood Laboratories Limited Not marketed
Apixaban Pinewood 5 mg film-coated tablets
PA0281/259/002
Apixaban Pinewood Laboratories Limited Not marketed
Apixaban Rowa 2.5 mg Film-coated tablets
PA0074/098/001
Apixaban Rowa Pharmaceuticals Limited, Not marketed
Apixaban Rowa 5 mg Film-coated tablets
PA0074/098/002
Apixaban Rowa Pharmaceuticals Limited, Not marketed
Apixaban Rowex 2.5 mg film-coated tablets
PA0711/303/001
Apixaban Rowex Limited, Not marketed
Apixaban Rowex 5 mg film-coated tablets
PA0711/303/002
Apixaban Rowex Limited, Not marketed
Apixaban Teva 2.5 mg film-coated tablets
PA0436/049/001
Apixaban Norton Waterford Not marketed
Apixaban Teva 5 mg film-coated tablets
PA0436/049/002
Apixaban Norton Waterford Not marketed
Apixaban Viatris 2.5 mg film-coated tablets
PA23266/058/001
Apixaban Viatris Limited Not marketed
Apixaban Viatris 5 mg film-coated tablets
PA23266/058/002
Apixaban Viatris Limited Not marketed
Apixaban Viatris Pharma 2.5 mg film-coated tablets
PA23266/069/001
Apixaban Viatris Limited Not marketed
Apixaban Viatris Pharma 5 mg film-coated tablets
PA23266/069/002
Apixaban Viatris Limited Not marketed
Eliquis 0.15 mg granules in capsules for opening
EU/1/11/691/016
Apixaban Bristol-Myers Squibb/Pfizer EEIG โ€”
Eliquis 0.5 mg coated granule in sachet
EU/1/11/691/017
Apixaban Bristol-Myers Squibb/Pfizer EEIG โ€”
Eliquis 1.5 mg coated granule in sachet
EU/1/11/691/018
Apixaban Bristol-Myers Squibb/Pfizer EEIG โ€”
Eliquis 2 mg coated granule in sachet
EU/1/11/691/019
Apixaban Bristol-Myers Squibb/Pfizer EEIG โ€”
Eliquis 2.5 mg film-coated tablets
EU/1/11/691/001-005, 013
Apixaban Bristol-Myers Squibb Pharma EEIG โ€”
Eliquis 5 mg film-coated tablets
EU/1/11/691/006-012
Apixaban Bristol-Myers Squibb Pharma EEIG โ€”
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 12 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.